| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO2000032551A9 Sertraline hydrochloride polymorphs |
| 07/19/2001 | WO2000009616A8 Biologically active fraction of vegetable melanin, process for its production and its use |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010008947 Administering derivative of 2-amino-4-phenyl-4-oxo-butyric acid which acts as kynureninase/kynurenine-3-hydroxylase enzyme inhibitor; neurodegenerative diseases |
| 07/19/2001 | US20010008903 Dioxinoindole and thienobenzodioxin compounds which are ht3 receptor antagonists and are used to treat central nervous system disorders |
| 07/19/2001 | US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/19/2001 | US20010008884 Administering to the patient a combination of antidepressant or a monoamine oxidase inhibitor, vitamin B12, and precursor or inducer of a neurotransmitter, e.g. L-phenylalanine |
| 07/19/2001 | US20010008639 Reducing dosage; analgesics |
| 07/19/2001 | DE10001879A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors useful for the treatment and prevention of e.g. ischemic disorders, infarction, arrhythmia, angina pectoris and stroke |
| 07/19/2001 | DE10001785A1 Use of NK-1 receptor antagonists for treatment of restless legs syndrome |
| 07/19/2001 | CA2401374A1 Method for the preparation of citalopram |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397283A1 New imidazole derivatives |
| 07/19/2001 | CA2397199A1 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | CA2397081A1 Novel vitamin d analogues |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396950A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | CA2396199A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | CA2396026A1 Phenanthridine-n-oxides |
| 07/19/2001 | CA2396007A1 Piperidine and piperazine derivatives |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/18/2001 | EP1116722A1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
| 07/18/2001 | EP1116716A1 Piperidine and piperazine compounds for use in the treatment of Alzheimer |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115861A2 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115851A1 Method of screening for large offspring syndrome |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115743A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 07/18/2001 | EP1115738A1 Synthesis of cyclic peptides |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115721A1 Pyrimidone derivatives |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115718A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 07/18/2001 | EP1115716A1 2-phenylpyran-4-one derivatives |
| 07/18/2001 | EP1115712A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 07/18/2001 | EP1115708A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 07/18/2001 | EP1115703A1 Cyclic ester or amide derivatives |
| 07/18/2001 | EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 07/18/2001 | EP1115425A1 Autoantibody inhibitors |
| 07/18/2001 | EP1115421A2 Use of glp-1 or analogs in treatment of stroke |
| 07/18/2001 | EP1115418A2 Aglyco products and methods of use |
| 07/18/2001 | EP1115416A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 07/18/2001 | EP1115415A1 Use of composition in the treatment of schizophrenia |
| 07/18/2001 | EP1115412A1 Neuroimmunophilins for selective neuronal radioprotection |
| 07/18/2001 | EP1115405A1 Use of certain drugs for treating nerve root injury |
| 07/18/2001 | EP1115404A1 Use of prostanoid antagonists for the treatment of primary headache disorders |
| 07/18/2001 | EP1115402A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas |
| 07/18/2001 | EP1115393A1 Sulfonamide derivatives |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP1115384A1 Fentanyl composition for the treatment of acute pain |
| 07/18/2001 | EP1115383A1 Pharmaceutical composition for the treatment of acute disorders |
| 07/18/2001 | EP1115372A2 Fast dissolving orally consumable films |
| 07/18/2001 | EP1034171B1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/18/2001 | CN1304411A Acetylcholine enhancers |
| 07/18/2001 | CN1304409A Indol-3-Yl-cyclohexyl amide derivatives for treatment of depression (5-HT1 receptor antagonists) |
| 07/18/2001 | CN1304408A N-benzodioxanylmethyl-piperidyl-methylamine compounds having effinity for 5-HT receptors |
| 07/18/2001 | CN1304407A N-aryloxyethyl-indoly-alkylamines for treatment of depression |
| 07/18/2001 | CN1304403A N-aryloxyethyl-indoly-alkylamines for treatment of depression (5-HT1A receptor active agents) |
| 07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 07/18/2001 | CN1304397A Hyperforin derivatives, the use thereof and formulations containing them |
| 07/18/2001 | CN1304314A Extracts of i(hypericum perforatum) and formulations containing them |
| 07/18/2001 | CN1304312A Composition and method for treatment and preventing of arthritis and/or autoimmune diseases |
| 07/18/2001 | CN1304311A Bridged indenopyrrolocarbazoles |
| 07/18/2001 | CN1304308A Aqueous process for manufacturing paroxetine solid dispersions |
| 07/18/2001 | CN1304307A 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists |
| 07/18/2001 | CN1303694A Medicine for curing vesanic disease by adopting head osmotic therapy |
| 07/18/2001 | CN1303693A Medicine for curing epilepsy by adopting head osmotic therapy |
| 07/18/2001 | CN1303691A Health-care Chinese herbal medicine cigarette for stopping smoking and its formula |
| 07/18/2001 | CN1303690A Drugs-stopping medicine made of Chinese medicinal materials |
| 07/18/2001 | CN1303674A Alprazolam nasal spray |
| 07/18/2001 | CN1068598C Resolution of 1-azabicyclo [2.2.2] octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl) phenyl]methyl] |
| 07/18/2001 | CN1068592C Imidazole derivatives having affinity for alpha 2 receptors activity |
| 07/18/2001 | CN1068583C N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
| 07/18/2001 | CA2332169A1 Treatments for obesity and methods for identifiying compounds useful for treating obesity |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262127 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/17/2001 | US6262123 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 07/17/2001 | US6262121 Oily patches for external use containing diclofenac sodium |
| 07/17/2001 | US6262118 Therapy of type 2 diabetes in a mammal by administering (-) 4-chlorophenyl-(3-trifluoromethylphenoxy)acetic acid derivative |
| 07/17/2001 | US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 07/17/2001 | US6262111 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 07/17/2001 | US6262106 Adamantanecarboximidamide derivatives and their use as NMDA antagonists |
| 07/17/2001 | US6262104 Selective delta opioid agonists and antagonists |
| 07/17/2001 | US6262103 Alzheimer's disease. |
| 07/17/2001 | US6262098 Estrogen receptor modulators |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262095 Use of tricyclic derivatives of 1,4-dihydro-1,4-dioxo-1H-naphthalene, novel compounds obtained and their application in theraphy |
| 07/17/2001 | US6262089 Using these compounds to treat diseases associated with amyloidosis, such as alzheimer's disease, maturity onset diabetes mellitus, familial amyloid polyneuropathy, scrapie, and kreuzfeld-jacob disease. |
| 07/17/2001 | US6262087 Indane or dihydroindole derivatives |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |